The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
26
370: Pharma sours on the U.K., plus biotech M&A...
37 min
27
369: Trump, Chinese biotech, and an industry ca...
35 min
28
368: New stakes in the vaccine dispute and a bo...
26 min
29
367: The ouster of CDC's director, biotech vent...
27 min
30
366: Viking’s obesity flop, ‘pharma to table’ d...
24 min
31
365: Vinay Prasad’s return, animal testing alte...
26 min
32
364: Closing a zombie biotech, and Lilly's disa...
36 min
33
363: What Vinay Prasad’s ouster means for biote...
43 min
34
362: A mother’s perspective on Sarepta’s gene t...
35 min
35
361: Inside an FDA drug rejection, and layoffs ...
42 min
36
360: NIH grant cuts, FDA transparency questions...
24 min
37
359: Vaccine policy frays, CDC nominee in the h...
33 min
38
358: FDA's gene therapy turmoil, and an alterna...
29 min
39
357: The upheaval of CDC's vaccine panel, and d...
45 min
40
356: An AI experiment at the FDA & Novo trailin...
32 min
41
355: Moderna’s vaccine hit, the MAHA report, an...
35 min
42
354: Uncertainty in CRISPR world and the start ...
40 min
43
353: Trump's drug-pricing plan and a potential ...
24 min
44
352: A firebrand takes oversight of vaccines, g...
25 min
45
351: It's gonna be May (in biotech)
34 min
46
350: Pharma tariffs, and a 'sunshine day' for b...
30 min
47
349: BIO's John Crowley on RFK Jr. and tariffs,...
39 min
48
348: Cuts, ousters and drama at the FDA
30 min
49
347: More HHS upheaval, 23andMe's bankruptcy, a...
30 min
50
346: Zealand's obesity strategy and Immunovant'...
42 min